Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
![Essential](https://www.g2intelligence.com/wp-content/uploads/2023/11/Essential.png)
![62934_G2_Subscription Website Images_JL V1](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V1.png)
![Special-Report](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Report.png)
![62934_G2_Subscription Website Images_JL V12](https://www.g2intelligence.com/wp-content/uploads/2023/11/62934_G2_Subscription-Website-Images_JL-V12.png)
![Special-Analysis](https://www.g2intelligence.com/wp-content/uploads/2023/11/Special-Analysis.png)
![Elite](https://www.g2intelligence.com/wp-content/uploads/2023/11/Elite.png)
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
![paper_magnifing_glass_512](https://www.g2intelligence.com/wp-content/uploads/2023/11/paper_magnifing_glass_512.png)
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
Bill to Regulate LDTs Advances, but Is No Slam Dunk for Final Passage
Now that the finishing touches have been put on LDT-related legislation, what is the likelihood that it will pass?
Three New Monkeypox Testing Solutions Launched
Two PCR assays and a PCR point-of-care solution from three different companies aim to help with diagnosing cases, tracking new variants.
Liquid Biopsy Can Rule Out Post-Surgery Chemotherapy for Colon Cancer
A post-surgery liquid biopsy test capable of detecting ctDNA could eliminate the need for chemotherapy for some stage II cancer patients.
Managed Care Company Settles False Claims Allegations for $4.6 Million
In this Labs in Court Weekly roundup, Molina allegedly submitted claims while not properly supervising and licensing mental health staff.
Partnership Aims to Improve Healthcare Delivery via Technology
Mayo Clinic and Sheba Medical Center sign an agreement aiming to develop and release health technologies more quickly.
A Faster, Simpler Liquid Biopsy Assay for Breast Cancer
Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.
Artificial Intelligence and Revenue Cycle Management
This free webinar will cover recent changes in AI and the medical billing world, as well as the key benefits AI brings to billing.
Increased Telehealth Use Did Not Spike Total Outpatient Visits
A recently released preprint study shows that expanded telehealth coverage did not lead to an increase in volume for outpatient E&M services.
Novel Pathogen Reduction Technologies Effectively Treat Whole Blood Products
Researchers are actively developing PRTs for use in whole blood products to target bacteria and viruses, including SARS-CoV-2.
ACP: Current Physician Payment Model Needs to Be Reformed
Position paper offers seven key recommendations for addressing inequities and disparities in access to quality health care in the US.